Changes in brain serotonin turnover, body and head shakes in kainic acid-treated rats

Pharmacology and Toxicology

Volumn 92, Issue 3, 2003, Pages 143-147

  Osorio Rico, Laura ^a   Mancera Flores, Mayra ^a   Ríos, Camilo ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; DOPAMINE; KAINIC ACID; KETANSERIN; METITEPINE; MONOAMINE OXIDASE INHIBITOR; NEUROTOXIN; NEUROTRANSMITTER; NORADRENALIN; PARGYLINE; SEROTONIN; SEROTONIN ANTAGONIST;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SEROTONIN BRAIN LEVEL;

AMYGDALA; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CEREBRAL CORTEX; CORPUS STRIATUM; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; INJECTIONS, INTRAPERITONEAL; KAINIC ACID; KETANSERIN; MALE; METHIOTHEPIN; RATS; RATS, WISTAR; SEIZURES; SEROTONIN; SEROTONIN ANTAGONISTS;

ANIMALIA;

EID: 0037354776     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2003.920307.x     Document Type: Article

References (39)

1. Akaike, K., S. Tanaka, H. Tojo, S. Fukumoto, S. Imamura & M. Takigawa: Kainic acid-induced dorsal and ventral hippocampal seizures in rats. Brain Res. 2001, 900, 65-71.
2. Altagracia, M., A. Monroy-Noyola, L. Osorio-Rico, J. Kravzov, R. Alvarado-Calvillo, J. Manjarrez & C. Rios: Dapsone attenuates kainic acid-induced seizures in rats. Neurosci Letters 1994, 17, 652-654.
3. Bacon, W. L. & S. G. Beck: 5 hydroxytryptamine7 receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells. Pharm. Exp. Therap. 2000, 294, 672-679.
4. Barnes, N. & T. Sharp: A review of central 5 -HT receptors and their function. Neuropharmacology 1999, 38, 1083-1152.
5. Bedard, P. & C. J. Pycock: Wet-dog shake behavior in the rat: a possible quantitative model of central 5-hydroxytryptamine activity. Neuropharmacol. 1977, 16, 663-670.
6. Ben-Ari, Y., E. Tremblay, D. Riche, G. Ghilini & R. Naquet: Electroencephalographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculine or pentetranzole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 1981, 6, 1361-1391.
7. Bourne, J. A., P. Fosbraey & J. Halliday: Changes in striatal electrocephalography and neurochemistry induced by kainic acid seizures are modified by dopamine receptor antagonists. Eur. J. Pharm. 2001, 413, 189-198.
8. Bozzi, Y., D. Vallone & E. Borelli: Neuroprotective role of dopamine against hippocampal cell death. J. Neurosci. 2000, 15, 8643-8649.
9. Bradley, P. B., G. Engel, W. Feniuk, J. R. Fozard, P. A. Humphrey, D. M. Middlemiss, E. J. Mylecharane, B. P. Richardson & P. R. Saxena: Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacol 1986, 25, 563-576.
10. Brazco, J. J., M. J. Bannon, B. S. Bunney & R. H. Roth: Intrastriatal kainic acid: Acute effects on electrophysiological and biochemical measures of nigrostriatal dopaminergic activity. J. Pharm. Exp. Therap. 1981, 6, 289-293.
11. Cadet, J. L: Participation of the serotonin2 receptor in the iminodipropionitrile-induced dyskinetic syndrome. Exp. Neurol. 1988, 99, 589-593.
12. Cazalets, J. R., Y. Squlli-Houssaini & F. Clarac: Activation of central pattern generators for locomotion by serotonin and excitatory amino acids in neonatal rat. J. Physiol. 1992, 455, 187-204.
13. 2 receptor agonist B-HT 920 on rat grooming. Eur. J. Pharm. 1992, 216, 345-350.
14. 2 antagonist, on neuronal damage and local cerebral blood flow following transient cerebral ischemia in gerbils. Brain Res 1994, 636, 103-106.
15. Gerson, S. C. & R. J. Baldessarini: Motor effects of serotonin in central nervous system. Life Sci. 1980, 27, 1435-1451.
16. 3H-DOPA in various regions of the brain. J. Neurochem. 1966, 13, 655-669.
17. Hajnal, A., L. Lenard, A. Czurko, P. Sandor & Z. Karadi: Distribution and time of appearance of "dark" neurons and EEG activity after amygdaloid kainate lesion. Brain Res. Bull. 1997, 43, 235-243.
18. Heggli, D. E., A. Aamodt & D. Malthe-Sorenssen: Kainic acid neurotoxicity; effect of systemic injection on neurotransmitter markers in different brain regions. Brain Res. 1981, 230, 253-262.
19. 2 sites in cortex and amygdala. Brain Res. 1993, 614, 37-44.
20. Jacobs, B. L.: Minireview an animal behavior model for studying central serotonergic synapses. Life Sci. 1976, 19, 777-786.
21. Lucki, I., K. M. Eberle & N. Minugh-Purvis: The role of the aural head shake reflex in serotonin-mediated head shaking behavior. Psychopharmacol. 1987, 92, 150-156.
22. Lothman, E. W. & R. C. Collins: Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res. 1987, 218, 299-318.
23. Neff, N. H. & T.N. Tozer: In vivo measurement of brain serotonin turnover. Adv. Pharmacol. 1968, 6(PtA), 97-109.
24. O'Dell, L. E., M. J. Kreifieldt, F. R. George & M. C. Ritz: The role serotonin (2) receptors in mediating cocaine-induced convulsions. Pharmacol Biochem. Behav. 2000, 65, 677-681.
25. Osorio-Rico, L., S. Galván-Arzate & C. Ríos: Thallium increases monoamine oxidase activity and serotonin turnover rate in rat brain regions. Neurotoxicol. Teratol. 1995, 17, 1-5.
26. Pappert, E. J., C. G. Goetz, G. T. Stebbins, M. Belden & P. M. Carvey: 5- Hydroxytryptophan-induced myoclonus in guinea pigs: Mediation through 5-HT1/2 receptor subtypes. Eur. J. Pharmacol. 1998, 347, 51-56.
27. Pappert, E. J., C. G. Goetz, T. Q. Vu, Z. D. Ling, S. Leurgans, R. Raman & P. M. Carvey: Animal model of posthypoxic myoclonus: effects of serotonergic antagonists. Neurol. 1999, 52, 16-21.
28. Roberts, C., G. W. Price, L. Gaster, B. J. Jones, D. N. Middlemiss & C. Routledge: Importance of 5-HT1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in freely-moving guinea-pig. Neuropharmacol 1997, 36, 549-557.
29. Routledge, C., S. M. Bromidge, S. F. Moss, G. W. Price, W. Hirst, H. Newman, G. Riley, T. Gager, T. Stean, N, Upton, S. E. Clarke, A. M. Brown & D. N. Middlemiss: Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist. Brit. J. Pharmacol. 2000, 130, 1606-1612.
30. Satoh, T., K. Sawaki & M. Kawaguchi: Pharmacological analysis of local anesthetic tolycaine-induced convulsions by modification of monoamines in rat brain. Pharmacol. Toxicol. 1996, 79, 305-311.
31. Siegel, S.: Non parametric statistics for the behavioral sciences. McGraw-Book Company, New York, U.S.A., 1980.
32. Smith, R., R. J. Barrett & E. Sanders-Bush: Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor. J. Pharmacol. Exp. Therap. 1995, 275, 1050-1057.
33. Sperk, G., H. Lassmann, H. Baran, S. J. Kish, F. Seitelberger & O. Hornykiewicz: Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 1983, 10, 1301-1315.
34. Sperk, G., H. Lassman, F. Seitelberger & O. Hornykiewicz: Kainic acid-induced seizures: Dose-relationship of behavioral, neurochemical and histopathological changes. Brain Res. 1985, 338, 289-295.
35. Steel, R. G. D. & J. H. Torrie: Principles and procedures of statistics. McGraw-Hill Inc., U.S.A., 1980.
36. Stewart, R. M., J. H. Growdon, D. Cancian & R. J. Baldessarini: 5-hydroxytryptophan-induced myoclonus: increased sensivity to serotonin after intracranial 5,7-dihydroxytryptamine in the adult rat. Neuropharmacol 1976, 15, 449-455.
37. Toth, M. & L. Tecott: Transgenic approaches to epilepsy. Adv. Neurol. 1999, 79, 291-296.
38. Tuski, L., J. Czuczwar, W. Turski & Z. Kleirok: Induction of wet dog shakes by intracerebroventricular bethanechol in rats. Antagonism by neurotransmitter receptor blockers. Pharmacology 1982, 24, 105-110.
39. Watanabe, K., C. R. Ashby, H. Katsumori & Y. Minabe: The effect of acute administration of various selective 5-HT receptor antagonists on focal hippocampal seizures in freely-moving rats. Eur. J. Pharmacol. 2000, 398, 239-246.